Effects of Health Education on Physical Activity Promotion Based on PRECEDE-PROCEED Model Among Adolescents

October 10, 2024 updated by: Zeng Linxian

Effects of Health Education on Physical Activity Promotion Based on PRECEDE-PROCEED Model Among Adolescents in Yunnan, China

A randomized controlled trial (RCT) was conducted to evaluate the changes in physical activity in adolescents before and after a health education program intervention based on the PRECEDE-PROCEED model.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Based on the overall theoretical framework of the PRECEDE-PROCEED model, starting from the five steps of the PRECEDE-PROCEED model, namely, sociological evaluation, epidemiological evaluation, behavioral environment evaluation, educational organization evaluation, and management policy evaluation, a cross-sectional study was conducted to understand the physical activity level, vision, physical fitness level, social support, exercise self-efficacy, perceived benefits and barriers of exercise, and school sports environment support of adolescents of different genders and grades in Yunnan Province, China, and to analyze the paths of influencing factors. Based on the PRECEDE-PROCEED model, a health education program for promoting physical activity suitable for adolescents in Yunnan Province, China was developed, and an experimental intervention was conducted using a health education program based on the PRECEDE-PROCEED model. The effect of health education based on the PRECEDE-PROCEED model on promoting physical activity among adolescents in Yunnan Province was explored, so as to achieve the improvement of adolescent physical activity level and health promotion, and it is expected to provide a reference for the promotion of physical activity and physical health of adolescents in China.

Inclusion criteria:

  • 15 to 18 years old, resident in Kunming, Yunnan, China;
  • Adolescents who are understand the information that explained by the researcher and agree to be included in the study；
  • Voluntarily participate in the experiment, cooperate with the research during the research process, and sign the informed consent；
  • Adolescents who healthy to participate in physical activity (measured by PAR-Q).

Exclusion criteria:

  • Mental illness with cognitive impairment;
  • People with speech or ear dysfunction;
  • Recent or upcoming surgery (within 3 months), or commonalities;
  • Subjects During the research period, if symptoms of discomfort occur, they are asked to stop and withdraw according to the subject's own will;
  • Have participated in similar research in the past. People who meet any of the exclusion criteria are not included in the study.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
194

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Yunnan
      • Kunming, Yunnan, China, 650500
        • Anning No. 1 Middle School in KunMing,Yunnan Province, China

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 15 to 18 years old, resident in Kunming, Yunnan, China;
  • Adolescents who are understand the information that explained by the researcher and agree to be included in the study；
  • Voluntarily participate in the experiment, cooperate with the research during the research process, and sign the informed consent；
  • Adolescents who healthy to participate in physical activity (measured by PAR-Q).

Exclusion Criteria:

  • Mental illness with cognitive impairment;
  • People with speech or ear dysfunction;
  • Recent or upcoming surgery (within 3 months), or commonalities;
  • Subjects During the research period, if symptoms of discomfort occur, they are asked to stop and withdraw according to the subject's own will;
  • Have participated in similar research in the past. People who meet any of the exclusion criteria are not included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention group and Control group (2 groups)
This study held a group meeting before the formal experiment to guide all participants in advance and explain the entire experimental process to them in detail. Students with questions were given a unified and detailed explanation. Each participant received a health education manual and a physical activity record book. During the experimental stage, the researchers reminded the participants to attend the health education lectures and physical activity experiments on time. Participants were required to participate in the experiment according to the experimental content.
Behavioral: Intervention group

• Intervention group:

Participants were invited to participate in a 20-minute interactive learning course (PPT lecture) and a 25-minute physical activity.The intervention lasted for 12 weeks, twice a week, 45 minutes each time, for a total of 1080 minutes.
No Intervention: control group
Control group: Participants only received a logbook to record their physical activity every week and participated in regular physical exercise activities at school

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Health education based on the PRECEDE-PROCEED model has a positive impact on promoting physical activity among adolescents in Yunnan Province
Time Frame: 12 weeks
This study collected data via questionnaires, physical fitness tests, and vision assessments. Instruments included validated questionnaires-ASAFA-C, Q-SPACE-C, EBBS-CN, PAQ-CN, and S-PASESC-measuring social support, school environment, perceived benefits/barriers, activity levels, and self-efficacy. Physical tests per NSPFH 2014 included BMI, sprints, runs, jumps, pull-ups/sit-ups, and vital capacity. Data were analyzed using descriptive statistics and repeated measures ANOVA/MANOVA over four measurements.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Zeng Linxian

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Linxian Zeng, PHD, Universiti Sains Malaysia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 5, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 22, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 30, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
October 8, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 10, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
October 15, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
October 15, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 10, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • USM/JEPeM/22110706

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Excessive Physical Exertion

Clinical Trials on Intervention group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings